GIROLAMI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.654
EU - Europa 2.731
AS - Asia 1.830
SA - Sud America 240
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 48
OC - Oceania 15
Totale 8.585
Nazione #
US - Stati Uniti d'America 3.539
RU - Federazione Russa 713
IT - Italia 702
PL - Polonia 631
SG - Singapore 532
CN - Cina 488
HK - Hong Kong 227
VN - Vietnam 192
BR - Brasile 178
IE - Irlanda 151
KR - Corea 139
SE - Svezia 123
DE - Germania 100
FI - Finlandia 93
CA - Canada 81
FR - Francia 67
BD - Bangladesh 57
GB - Regno Unito 47
IN - India 46
NL - Olanda 38
JO - Giordania 32
JP - Giappone 32
AR - Argentina 27
ID - Indonesia 27
AU - Australia 14
EC - Ecuador 12
MX - Messico 11
ES - Italia 10
MA - Marocco 10
ZA - Sudafrica 10
BE - Belgio 9
CO - Colombia 9
TN - Tunisia 9
IR - Iran 8
CH - Svizzera 7
IQ - Iraq 7
UA - Ucraina 7
AT - Austria 6
IL - Israele 6
RO - Romania 6
TR - Turchia 6
CR - Costa Rica 5
GR - Grecia 5
JM - Giamaica 5
NG - Nigeria 5
PH - Filippine 5
PK - Pakistan 5
CI - Costa d'Avorio 4
HN - Honduras 4
LT - Lituania 4
CL - Cile 3
KZ - Kazakistan 3
PR - Porto Rico 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TC - Turks e Caicos 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
VI - Stati Uniti Isole Vergini 1
Totale 8.519
Città #
Warsaw 627
Santa Clara 538
Ashburn 481
Singapore 398
San Jose 208
Fairfield 206
Hong Kong 201
Dublin 148
Seoul 138
Hefei 131
Chandler 127
North Bergen 106
Seattle 101
Milan 100
Beijing 94
Houston 94
Dallas 93
Cambridge 81
Council Bluffs 81
Rome 81
Florence 79
Wilmington 78
Woodbridge 76
Los Angeles 65
Helsinki 64
New York 63
Buffalo 54
Munich 52
Hanoi 51
Lawrence 46
Ann Arbor 45
Altamura 41
Ho Chi Minh City 38
Lauterbourg 34
Moscow 32
The Dalles 27
Dong Ket 26
Princeton 26
Tokyo 26
Chicago 24
Jakarta 23
Boston 22
Shanghai 20
Toronto 19
Turku 19
Kent 18
Phoenix 18
Frankfurt am Main 17
Naples 16
Ottawa 16
Bologna 14
San Diego 14
São Paulo 14
Turin 14
Columbus 13
Genoa 13
Paris 13
Melbourne 12
Mumbai 11
Medford 10
Brasília 9
Chennai 9
Haiphong 9
Montreal 9
Nuremberg 9
Philadelphia 9
Venice 9
Washington 9
Bengaluru 8
Boardman 8
Clifton 8
Denver 8
London 8
Norwalk 8
San Francisco 8
Atlanta 7
Brooklyn 7
Brussels 7
Buenos Aires 7
Jacksonville 7
Orem 7
Reading 7
Redondo Beach 7
Stockholm 7
Tehran 7
Belmont 6
Breda 6
Da Nang 6
Johannesburg 6
Lappeenranta 6
Palermo 6
Bari 5
Bergamo 5
Bosisio Parini 5
Campinas 5
Curitiba 5
Figino 5
Lucca 5
Memphis 5
Miami 5
Totale 5.576
Nome #
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. 359
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations 325
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 325
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy 309
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 285
Position paper ANMCO: Cardiomiopatia ipertrofica: dalla diagnosi al trattamento 271
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 264
Clinical Exome Sequencing Revealed a De Novo FLNC Mutation in a Child with Restrictive Cardiomyopathy 252
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 239
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy insights from the sarcomeric human cardiomyopathy registry (SHaRe) 238
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 235
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 234
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy 229
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 227
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 225
Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation 218
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 214
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 204
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 204
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 201
Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications 198
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 198
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 194
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy. 191
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 188
Indicazioni all’esecuzione del test genetico nella diagnosi delle cardiomiopatie ad esordio pediatrico: percorso clinico della Società Italiana di Cardiologia Pediatrica 186
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 183
Genetic testing in pediatric cardiomyopathies: Implications for diagnosis and management 177
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: Impact of age, atrial remodelling, and disease progression 175
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome 174
Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy 170
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 155
Mitochondrial Energetics and Ca2+-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy 155
Hidden familial cardiomyopathies in children: Role of genetic testing 149
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy 148
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 147
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 146
Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy 130
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 106
Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy 63
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 53
ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment' 49
Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63 47
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patients 41
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 40
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 38
Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options 26
Totale 8.585
Categoria #
all - tutte 22.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022194 0 0 0 11 6 20 14 10 20 16 43 54
2022/2023636 46 127 36 28 52 105 90 42 81 5 18 6
2023/2024326 21 28 38 10 18 54 19 77 13 20 16 12
2024/20251.952 68 171 105 308 475 200 31 138 101 64 149 142
2025/20263.201 312 372 369 312 340 102 363 149 227 187 102 366
2026/2027771 244 154 241 132 0 0 0 0 0 0 0 0
Totale 8.585